Abstract
Thymosin β4 (43 aa) is a highly conserved acidic peptide, which regulates actin polymerization in mammalian cells by sequestering globular actin. Thymosin β4 is undergoing clinical trials as a drug for treatment of venous stasis ulcers, corneal wounds and injuries, as well as acute myocardial infarction. Currently, thymosin β4 is produced by a solid-phase chemical synthesis. Biotechnological synthesis of this peptide is difficult, because the N-terminal amino acid residue of thymosin β4 playing an essential role in the actin interaction is acetylated. In this study, we proposed a method for production of a thymosin β4 recombinant precursor and its directed chemical acetylation. Deacetylthymosin β4 was synthesized as a part of a hybrid protein containing thioredoxin and a specific TEV (tobacco etch virus) protease cleavage site. The following scheme was developed for purification of deacetylthymosin β4: (i) biosynthesis of a soluble hybrid protein (HP) in Escherichia coli, (ii) isolation of HP by ion exchange chromatography, (iii) cleavage of HP with TEV protease, and (iv) purification of deacetylthymosin β4 by ultrafiltration. N-Terminal acetylation of the serine residue of deacetylthymosin β4 was performed with acetic anhydride under acidic conditions (pH 3.0). The reaction yield was 55%. Thymosin β4 was finally purified by reverse-phase HPLC. The proposed method of isolation of recombinant thymosin β4 can be scaled-up and provide a highly purified preparation in a yield of 20 mg per 1 L of culture suitable for use in medical practice.
Similar content being viewed by others
Abbreviations
- DDT:
-
D,L-dithiothreitol
- HP:
-
hybrid protein
- IPTG:
-
isopropyl-β-D-thiogalactopyranoside
- PMSF:
-
phenylmethylsulfonyl fluoride
- Tβ4:
-
thymosin β4
- TEV:
-
tobacco etch virus
References
Goldstein, A.L., Slater, F.D., and White, A., Proc. Natl. Acad. Sci. USA, 1966, vol. 56, pp. 1010–1014.
Safer, D., Elzinga, M., and Nachmias, V.T., J. Biol. Chem., 1991, vol. 266, pp. 4029–4032.
Mannherz, H.G. and Hannappel, E., Cell Motil. Cytoskeleton, 2009, vol. 66, pp. 839–851.
Huff, T., Müller, C.S., Otto, A.M., Netzker, R., and Hannappel, E., Int. J. Biochem. Cell Biol., 2001, vol. 33, pp. 205–220.
Malinda, K.M., Goldstein, A.L., and Kleinman, H.K., FASEB J., 1997, vol. 11, pp. 474–481.
Philp, D., Huff, T., Gho, Y.S., Hannappel, E., and Kleinman, H.K., FASEB J., 2003, vol. 17, pp. 2103–2105.
Grant, D.S., Kinsella, J.L., Kibbey, M.C., LaFlamme, S., Burbelo, P.D., Goldstein, A.L., and Kleinman, H.K., J. Cell Sci., 1995, vol. 108, pp. 3685–3694.
Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A.L., and Kleinman, H.K., Wound Rep. Reg., 2003, vol. 11, pp. 19–24.
Sosne, G., Chan, C.C., Thai, K., Kennedy, M., Szliter, E.A., Hazlett, L.D., and Kleinman, H.K., Exp. Eye Res., 2001, vol. 72, pp. 605–608.
Hinkel, R., El-Aouni, C., Olson, T., Horstkotte, J., Mayer, S., Müller, S., Willhauck, M., Spitzweg, C., Gildehaus, F.J., Münzing, W., Hannappel, E., Bock-Marquette, I., DiMaio, J.M., Hatzopoulos, A.K., Boekstegers, P., and Kupatt, C., Circulation, 2008, vol. 117, pp. 2232–2240.
Sosne, G., Qiu, P., Christopherson, P.L., and Wheater, M.K., Exp. Eye Res., 2007, vol. 84, pp. 663–669.
Sosne, G., Siddiqi, A., and Kurpas-Wheater, M., Invest. Opthalmol. Vis. Sci., 2004, vol. 45, pp. 1095–1200.
Bock-Marquette, I., Saxena, A., White, M.D., DiMaio, M., and Srivastava, D., Nature, 2004, vol. 432, pp. 466–472.
Dunn, S.P., Heidemann, D.G., Chow, C.Y., Crockford, D., Turjman, N., Angel, J., Allan, C.B., and Sosne, G., Arch. Ophthalmol., 2010, vol. 128, pp. 636–638.
Crockford, D., Turjman, N., Allan, C., and Angel, J., Ann. N.Y. Acad. Sci., 2010, vol. 1194, pp. 179–189.
Crockford, D., Ann. N.Y. Acad. Sci., 2007, vol. 1112, pp. 385–395.
Smart, N., Risebro, C.A., Melville, A.A., Moses, K., Schwartz, R.J., Chien, K.R., and Riley, P.R., Nature, 2007, vol. 445, pp. 177–182.
Li, X., Zheng, L., Peng, F., Qi, C., Zhang, X., Zhou, A., Liu, Z., and Wu, S., Protein. Expr. Purif., 2007, vol. 56, pp. 229–236.
Ho, J.H., Chuang, C.H., Ho, C.Y., Shih, Y.R., Lee, O.K., and Su, Y., Invest. Ophthalmol. Vis. Sci., 2007, vol. 48, pp. 27–33.
Zoubek, R.E. and Hannappel, E., Ann. N.Y. Acad. Sci., 2007, vol. 1112, pp. 435–441.
Riordan, J.F. and Vallee, B.L., Methods Enzymol., 1972, vol. 25, pp. 494–499.
Fraenkel Conrat, H., Methods Enzymol., 1957, vol. 4, pp. 247–269.
Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning. A Laboratory Manual, Second ed., Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989.
Gray, W.R. and Hartley, B.S., Biochem. J., 1963, vol. 89, pp. 379–380.
Laemmli, U.K., Nature, 1970, vol. 227, pp. 680–685.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J., J. Biol. Chem., 1951, vol. 193, pp. 265–275.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © K.A. Beyrakhova, V.N. Stepanenko, A.I. Miroshnikov, R.S. Esipov, 2011, published in Bioorganicheskaya Khimiya, 2011, Vol. 37, No. 2, pp. 223–232.
Rights and permissions
About this article
Cite this article
Beyrakhova, K.A., Stepanenko, V.N., Miroshnikov, A.I. et al. Biotechnological production of acetylated thymosin β4. Russ J Bioorg Chem 37, 198–206 (2011). https://doi.org/10.1134/S1068162011020026
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162011020026